
| For Immediate Release |
Contact: Elizabeth Funderburk |
| March 14, 2008 |
Tel: 202.429.9260 |
CHPA Elects Board and Officers at Annual Executive Conference
Washington, D.C.—Members of the board of directors of the Consumer Healthcare Products Association (CHPA) were elected at the Association’s March 12-14 Annual Executive Conference. John T. Hendrickson, executive vice president of global operations and supply chain, Perrigo Company, was re-elected as the association’s chair. Timothy G. Hayes, senior vice president & region head, North America, Bayer HealthCare LLC, continues his service as immediate past chair.
CHPA vice chairs:
- Patrick M. Lonergan, partner, president, NUMARK Laboratories;
- James J. Mackey, senior vice president, Sales & Operations, Consumer Healthcare, Schering-Plough HealthCare Products, Inc.;
- Ashley A. McEvoy, president, McNeil Consumer Healthcare;
- George M. Quesnelle, president, North America, Consumer Healthcare, GlaxoSmithKline; and
- Douglas A. Rogers, president, U.S. and Global New Business, Wyeth Consumer Healthcare.
CHPA board members:
- Christopher B. Ascher, executive vice president, Sales & Marketing, B.F. Ascher & Company, Inc.;
- Jay P. Borneman, Ph.D., chairman & chief executive officer, Hyland’s, Inc.;
- Timothy B. Brown, General Manager, North America Personal Health, the Procter & Gamble Company;*
- John K. Cowles, head, OTC North America, Novartis Consumer Health, Inc.; *
- Christopher D. DeWolf, president & chief executive officer, Lil’ Drug Store Products, Inc. (Business Development Committee chair);
- Michael J. Donnantuono, president & chief operating officer, Blistex Inc.;
- Gary R. Downing, chief executive officer, Lansinoh Laboratories, Inc.;
- Zan Guerry, chairman of the board & chief executive officer, Chattem, Inc.;
- James G. Hackett, senior vice president, Marketing & Research, Parade Publications Inc.;
- Patrick Hennig, vice president, Marketing and Sales, Boehringer Ingelheim Pharmaceuticals, Inc.;
- Jeffrey S. Himmel, chairman & chief executive officer, Himmel Pharmaceuticals Inc.;
- Carl J. Johnson, president & chief executive officer, Matrixx Initiatives, Inc.;
- partner
- Daniel R. Johnson, senior vice president, general counsel and secretary, Combe Incorporated;
- Stephen C. Johnson, executive vice president and general manager, Information Resources, Inc.;*
- Edward C. Kuehnle, president, Catalina Marketing Services, Catalina Marketing Corporation;
- David J. Long, vice president, North American Regulatory, Reckitt Benckiser Inc.;*
- Maureen P. Maldari, executive vice president, global director, Grey Group;*
- Mark Pettie, chairman and chief executive officer, Prestige Brands Holdings, Inc.;
- Gregory C. Pulido, chairman & chief executive officer, Humco Holding Group, Inc.;
- Adam D. Raczkowski, executive vice president, chief operating officer, chief financial officer, and general manager, W.F. Young, Inc.;
- Calvin W. Schmidt, general manager, Johnson & Johnson • Merck Consumer Pharmaceuticals Co.;
- Bill Seiden, senior vice president, Marketing & Sales, Taro Pharmaceuticals U.S.A., Inc.;
- Randy M. Sloan, executive vice president, general manager, Del Pharmaceuticals, Inc.;*
- Neill B. Walsdorf, Jr., president, Mission Pharmacal Company; and
- Akiyoshi Yoshida, Ph.D., president and chief executive officer, The Mentholatum Company, Inc.
Serving on the board ex officio as a committee chair:
- Susan Beavis, director, Regulatory Affairs-CMC, Johnson & Johnson Healthcare Products (Manufacturing Controls Committee chair);
- Barbara A. Kochanowski, Ph.D., director, Global Personal Health Product Safety and Regulatory Affairs, The Procter & Gamble Company (Scientific Affairs Committee chair);
- David C. Bernens, associate director, Healthcare External Relations, The Procter & Gamble Company (Public Affairs Committee chair);*
- Catherine A. Sohn, Pharm.D., senior vice president, WWBD & Strategic Alliances, Consumer Healthcare, GlaxoSmithKline (International Affairs Committee chair); and
- Peter N. Stevens, assistant general counsel, Consumer Healthcare, GlaxoSmithKline (Government Affairs Committee chair).
*denotes newly elected to this position
# # #
CHPA is the 127-year-old trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement products.
www.chpa-info.org
08-07/EA
|
|